Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Aisling Capital

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • Biotechnology
  • Digital Health
About
Aisling Capital invests $1.8B in innovative healthcare companies with over 150 years of combined healthcare experience.
Min check size
$10M
Max check size
$50M
Fund size
NPS

Investment Thesis

Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies. They seek to identify differentiated healthcare products, services and technologies that address unmet medical needs, and provide promising companies with meaningful capital resources.
Lead investor
Co Invest
Number of exits
Preferred contact method

Aisling Capital Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp